Anavex CTAD den 1. dec. 2022 TLD Alzheimer fase 2/3!!!
-
Anavex...Lecanemab med abstract https://www.nejm.org/doi/full/10.1056/NEJMoa2212948
Glemte at nævne alvorlige sideeeffects med Lecanemab - evt dødsfald, 14% hjerneblødninger etc.
Jeg håber for patienterne at Blarcamesine bliver foretrukne behandling.....
-
Dette fundet på "endpoints" med henvisning til et udleveret skriv:
"In the paper, which was released in conjunction with presentations at an Alzheimer's conference, trial investigators write that a definition of clinical meaningfulness "has not been established." And the relative lack of new information, following topline data unveiled in September, left experts asking for more - setting up a potential showdown to precisely define how big a difference the drug makes in patients' lives"
....
-
Et tidsskrift
BBC og andre kalder det et gennembrug. Uha godt med fremskridt. Men er det meningsfyldt for AD patienterne ?
-
-
Lyttede til Guggenheim præsentationen en gang til.
Missling gjorde særlig opmærksom på, at Anavex's tilgang med upstream behandling i AD var meget bedre end konkurrenternes grundet sygdommens kompleksitet. Han pointerede, at 30 mg stoppede AD og 50 mg forbedrede tilstanden hos AD pts.
Han er helt i skoven, hvis ikke der venter os noget fornuftigt fredag.
I min optik et raid fra en stor spiller for at få de der ryster på hånden til at sælge.
-
Mange prøver at analyser sig frem til hvad der sker:
https://seekingalpha.com/article/4561424-anavex-life-sciences-earnings-market-unimpressed-alzheimers-data-readout-arrives?mailingid=29847482&messageid=2800&serial=29847482.4879&utm_campaign=rta-stock-article&utm_medium=email&utm_source=seeking_alpha&utm_term=29847482.4879
-
Kan du i det hele taget sove
En Ihubskribent har set, at AD er ikke et target for 3-71 længere.
Therapeutic Candidates | Anavex Life Sciences
Explore Anavex's innovative therapeutic candidates targeting CNS disorders like Alzheimer's and Parkinson's, driven by cutting-edge precision medicine research.
Anavex Life Sciences (www.anavex.com)
Kunne være et godt tegn.
"Vi har det vi skal bruge"
-
Der må da komme en offentliggørelse af data inden de går på late news.
Spørgsmål er så om de kommer før børsen åbner eller efter.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind